According to the latest report by IMARC Group, titled "Asia Pacific DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the Asia Pacific DNA sequencing products market size reached US$ 4.2 Billion in 2022. DNA sequencing is a laboratory technique that is generally used for determining the exact order of bases or nucleotides in a deoxyribonucleic acid (DNA) molecule. These nucleotides include guanine (G), cytosine (C), adenine (A) and thymine (T), which are the foundation building blocks of nucleic acids and aid in encoding the biological information that cells use to operate and develop. Some of the common DNA sequencing products are purification systems, electrophoresis, genotyping, microarrays, sequencing primer, buffer and data science, intuitive bioinformatics and software tools. Due to the rising need to automate the sequencing process with improved efficacy, there has been a considerable increase in the demand for DNA sequencing products across the Asia Pacific region.
Asia Pacific DNA Sequencing Products Market Trends:
The market in the Asia Pacific is primarily driven by the growing prevalence of DNA-linked disorders or congenital malformations among the masses. Coupled with the rising population level suffering from cancer, this is creating a positive market outlook. This has encouraged numerous leading players to heavily invest in upgrading the overall bioinformatics infrastructure, which is providing lucrative opportunities in the overall DNA sequencing products market. Apart from this, continual technological advancements and the emergence of artificial intelligence (AI), the internet of things (IoT) and data analytics are significantly supporting the demand across the region. These DNA sequencing products assist expert researchers in understanding the complex structure of numerous types of diseases and in the production of personalized medicines, which, in turn, is driving the market. Other factors, such as rapid urbanization and digitization and extensive research and development (R&D) activities conducted by key players in the field of life science, are also impacting the market favorably across the Asia Pacific region. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 10.6 Billion by 2028, exhibiting a CAGR of 16.8% during 2023-2028.
- On the basis of the product type, the market has been segmented into consumables and reagents and equipments.
- Based on the application, the market has been classified into biomarkers, diagnostics, reproductive health, forensics, personalized medicine and others.
- On the basis of the end user, the market has been categorized into academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics and others.
- Based on the country, the market has been divided into China, Japan, India, South Korea, Australia, Indonesia and others.
- The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
|Base Year of the Analysis
||Product Type, Application, End User, Country
||China, Japan, India, South Korea, Australia, Indonesia, Others
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800